These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30814375)

  • 1. [Regulations of osteoclast formation and function by Wnt signals.].
    Kobayashi Y; Uehara S; Koide M
    Clin Calcium; 2019; 29(3):309-315. PubMed ID: 30814375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of bone metabolism by Wnt signals.
    Kobayashi Y; Uehara S; Udagawa N; Takahashi N
    J Biochem; 2016 Apr; 159(4):387-92. PubMed ID: 26711238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of osteoclast differentiation by Wnt signals].
    Kobayashi Y
    Clin Calcium; 2013 Jun; 23(6):831-8. PubMed ID: 23719495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Formation Is Coupled to Resorption Via Suppression of Sclerostin Expression by Osteoclasts.
    Koide M; Kobayashi Y; Yamashita T; Uehara S; Nakamura M; Hiraoka BY; Ozaki Y; Iimura T; Yasuda H; Takahashi N; Udagawa N
    J Bone Miner Res; 2017 Oct; 32(10):2074-2086. PubMed ID: 28543818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory mechanisms of sclerostin expression during bone remodeling.
    Koide M; Kobayashi Y
    J Bone Miner Metab; 2019 Jan; 37(1):9-17. PubMed ID: 30357564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone.
    Tu X; Delgado-Calle J; Condon KW; Maycas M; Zhang H; Carlesso N; Taketo MM; Burr DB; Plotkin LI; Bellido T
    Proc Natl Acad Sci U S A; 2015 Feb; 112(5):E478-86. PubMed ID: 25605937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of osteoclast function via Rho-Pkn3-c-Src pathways.
    Uehara S; Udagawa N; Kobayashi Y
    J Oral Biosci; 2019 Sep; 61(3):135-140. PubMed ID: 31400545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of osteoclast differentiation by Wnt signals.
    Kobayashi Y; Uehara S; Koide M; Takahashi N
    Bonekey Rep; 2015; 4():713. PubMed ID: 26157576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells.
    Ruiz P; Martin-Millan M; Gonzalez-Martin MC; Almeida M; González-Macias J; Ros MA
    Sci Rep; 2016 Nov; 6():36201. PubMed ID: 27804995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.
    Ramaswamy G; Kim H; Zhang D; Lounev V; Wu JY; Choi Y; Kaplan FS; Pignolo RJ; Shore EM
    Sci Rep; 2017 Mar; 7():45140. PubMed ID: 28338087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Roles of Wnt signaling in bone metabolism].
    Kobayashi Y
    Clin Calcium; 2012 Nov; 22(11):1701-6. PubMed ID: 23103814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth.
    Duan P; Bonewald LF
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):23-29. PubMed ID: 27210503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse.
    Sun W; Shi Y; Lee WC; Lee SY; Long F
    Bone; 2016 Apr; 85():1-8. PubMed ID: 26780446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
    Rossini M; Gatti D; Adami S
    Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/β-catenin signalling pathway.
    Du L; Nong MN; Zhao JM; Peng XM; Zong SH; Zeng GF
    Sci Rep; 2016 Aug; 6():32261. PubMed ID: 27554324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.
    Ping Z; Hu X; Wang L; Shi J; Tao Y; Wu X; Hou Z; Guo X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Mar; 51():513-525. PubMed ID: 28088671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling.
    Wang D; Weng Y; Guo S; Zhang Y; Zhou T; Zhang M; Wang L; Ma J
    Int J Mol Med; 2018 Feb; 41(2):729-738. PubMed ID: 29207140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
    Shin CS; Her SJ; Kim JA; Kim DH; Kim SW; Kim SY; Kim HS; Park KH; Kim JG; Kitazawa R; Cheng SL; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2200-12. PubMed ID: 16294273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Runx2 Controls Bone Resorption through the Down-Regulation of the Wnt Pathway in Osteoblasts.
    Haxaire C; Haÿ E; Geoffroy V
    Am J Pathol; 2016 Jun; 186(6):1598-609. PubMed ID: 27083516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
    Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
    Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.